(SNEX) Stonex - Ratings and Ratios
Commodity, Forex, Precious, Metals, Trading, Payments
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 32.0% |
| Value at Risk 5%th | 50.5% |
| Relative Tail Risk | -4.25% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.20 |
| Alpha | 36.03 |
| CAGR/Max DD | 1.48 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.536 |
| Beta | 0.998 |
| Beta Downside | 1.158 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.07% |
| Mean DD | 7.09% |
| Median DD | 6.66% |
Description: SNEX Stonex January 08, 2026
StoneX Group Inc. (NASDAQ: SNEX) is a diversified global financial-services firm that links corporates, institutional investors, retail traders and payment processors to markets across the United States, Europe, Latin America, the Middle East and Asia.
The business is organized into four operating segments: Commercial (risk-management, voice brokerage, physical commodity trading, financing and fixed-income dealing), Institutional (execution and clearing of exchange-traded and OTC products), Self-Directed/Retail (FX, precious-metals, CFDs, spread betting and bullion sales via Stonexbullion.com) and Payments (cross-border settlement services).
StoneX, originally founded in 1924 as INTL FCStone, rebranded in July 2020. In FY 2023 the company reported revenue of roughly $2.6 billion and an adjusted EBITDA margin near 13 %, reflecting strong fee income from its commercial hedging and FX businesses.
Key drivers for StoneX include global commodity price cycles (which boost physical trading volumes), central-bank policy shifts that affect FX volatility, and the ongoing growth of electronic retail trading platforms. The firm’s exposure to both physical and derivative markets gives it a diversified revenue base, but also makes earnings sensitive to macro-economic shocks such as sudden commodity price swings or abrupt changes in interest-rate expectations.
For a deeper quantitative look, you might explore ValueRay’s detailed SNEX valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (305.9m TTM) > 0 and > 6% of Revenue (6% = 7.94b TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 7.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.62% (prev 8.02%; Δ 1.60pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 4.41b > Net Income 305.9m (YES >=105%, WARN >=100%) |
| Net Debt (16.91b) to EBITDA (2.02b) ratio: 8.38 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.57 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (52.6m) change vs 12m ago 64.28% (target <= -2.0% for YES) |
| Gross Margin 99.16% (prev 2.01%; Δ 97.15pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 364.0% (prev 363.7%; Δ 0.33pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.34 (EBITDA TTM 2.02b / Interest Expense TTM 1.45b) >= 6 (WARN >= 3) |
Altman Z'' 2.37
| (A) 0.28 = (Total Current Assets 35.13b - Total Current Liabilities 22.40b) / Total Assets 45.27b |
| (B) 0.04 = Retained Earnings (Balance) 1.69b / Total Assets 45.27b |
| (C) 0.05 = EBIT TTM 1.95b / Avg Total Assets 36.37b |
| (D) 0.04 = Book Value of Equity 1.68b / Total Liabilities 42.89b |
| Total Rating: 2.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.18
| 1. Piotroski 4.50pt |
| 2. FCF Yield 19.46% |
| 3. FCF Margin 3.28% |
| 4. Debt/Equity 7.79 |
| 5. Debt/Ebitda 8.38 |
| 6. ROIC - WACC (= 5.41)% |
| 7. RoE 15.27% |
| 8. Rev. Trend 89.01% |
| 9. EPS Trend -77.03% |
What is the price of SNEX shares?
Over the past week, the price has changed by +0.75%, over one month by +7.17%, over three months by +5.93% and over the past year by +54.66%.
Is SNEX a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SNEX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 99 | -4% |
| Analysts Target Price | 99 | -4% |
| ValueRay Target Price | 142.3 | 37.9% |
SNEX Fundamental Data Overview January 10, 2026
P/S = 0.0412
P/B = 2.265
Beta = 0.463
Revenue TTM = 132.38b USD
EBIT TTM = 1.95b USD
EBITDA TTM = 2.02b USD
Long Term Debt = 17.52b USD (from longTermDebt, last quarter)
Short Term Debt = 782.0m USD (from shortTermDebt, last quarter)
Debt = 18.52b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.91b USD (from netDebt column, last quarter)
Enterprise Value = 22.30b USD (5.39b + Debt 18.52b - CCE 1.61b)
Interest Coverage Ratio = 1.34 (Ebit TTM 1.95b / Interest Expense TTM 1.45b)
EV/FCF = 5.14x (Enterprise Value 22.30b / FCF TTM 4.34b)
FCF Yield = 19.46% (FCF TTM 4.34b / Enterprise Value 22.30b)
FCF Margin = 3.28% (FCF TTM 4.34b / Revenue TTM 132.38b)
Net Margin = 0.23% (Net Income TTM 305.9m / Revenue TTM 132.38b)
Gross Margin = 99.16% ((Revenue TTM 132.38b - Cost of Revenue TTM 1.11b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev 1.87%)
Tobins Q-Ratio = 0.49 (Enterprise Value 22.30b / Total Assets 45.27b)
Interest Expense / Debt = 2.21% (Interest Expense 408.6m / Debt 18.52b)
Taxrate = 21.52% (23.5m / 109.2m)
NOPAT = 1.53b (EBIT 1.95b * (1 - 21.52%))
Current Ratio = 1.57 (Total Current Assets 35.13b / Total Current Liabilities 22.40b)
Debt / Equity = 7.79 (Debt 18.52b / totalStockholderEquity, last quarter 2.38b)
Debt / EBITDA = 8.38 (Net Debt 16.91b / EBITDA 2.02b)
Debt / FCF = 3.90 (Net Debt 16.91b / FCF TTM 4.34b)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.84% (Net Income 305.9m / Total Assets 45.27b)
RoE = 15.27% (Net Income TTM 305.9m / Total Stockholder Equity 2.00b)
RoCE = 9.98% (EBIT 1.95b / Capital Employed (Equity 2.00b + L.T.Debt 17.52b))
RoIC = 8.91% (NOPAT 1.53b / Invested Capital 17.17b)
WACC = 3.50% (E(5.39b)/V(23.91b) * Re(9.59%) + D(18.52b)/V(23.91b) * Rd(2.21%) * (1-Tc(0.22)))
Discount Rate = 9.59% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 29.65%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈2.78b ; Y1≈1.83b ; Y5≈832.8m
Fair Price DCF = 184.2 (EV 26.53b - Net Debt 16.91b = Equity 9.62b / Shares 52.2m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -77.03 | EPS CAGR: -52.69% | SUE: -4.0 | # QB: 0
Revenue Correlation: 89.01 | Revenue CAGR: 24.61% | SUE: 1.24 | # QB: 9
EPS next Quarter (2026-03-31): EPS=1.79 | Chg30d=+0.060 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-09-30): EPS=7.53 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+25.1% | Growth Revenue=+0.0%
EPS next Year (2027-09-30): EPS=8.54 | Chg30d=+0.120 | Revisions Net=+1 | Growth EPS=+13.4% | Growth Revenue=+0.0%
Additional Sources for SNEX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle